← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Zetroz Systems, Llc
Trumbull, CT
$15,351,618
Total funding
5
Grants
Funding over time
peak $3.8M · FY2015–25$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,351,618 · 5
By mechanism
R44$14,452,354 · 3
R43$899,264 · 2
Investigators at Zetroz Systems, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis$2,359,304
R44 · FY2025 · AG
Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis$2,196,474
R44 · FY2024 · AG
Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain$1,578,495
R44 · FY2024 · MD
Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain$1,482,405
R44 · FY2023 · MD
Clinical Optimization of Ultrasonic Drug Delivery Technologies for US Veteran Populations that Experience Health Disparities with Arthritis and Chronic Pain$1,457,643
R44 · FY2025 · MD
Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis$1,442,543
R44 · FY2020 · AG
Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis$1,438,616
R44 · FY2022 · AG
Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis$1,427,916
R44 · FY2021 · AG
Self-Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Underserved Populations$400,000
R44 · FY2017 · MD
Self-Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Underserved Populations$400,000
R44 · FY2016 · MD
Self-Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Underserved Populations$268,958
R44 · FY2015 · MD
Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain$233,597
R43 · FY2021 · MD
Daily and localized NSAID sonophoresis for symptomatic treatment of knee osteoarthritis$224,176
R43 · FY2018 · AG
Daily and localized NSAID sonophoresis for symptomatic treatment of knee osteoarthritis$223,719
R43 · FY2019 · AG
Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain$217,772
R43 · FY2020 · MD